Aims and Scope - Journal of Cellular and Molecular Pharmacology

Journal of Cellular and Molecular Pharmacology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Aims and Scope

 » Journal of Cellular and Molecular Pharmacology (JCMP) aims to promote clinical and translational research on drug design, development and delivery that can effectively address the disorders and challenges at the cellular and molecular level, which may turn chronic if unattended at the formative stages.


Journal of Cellular and Molecular Pharmacology caters to the diversified needs of pharmacists, chemists and druggists, oncologists, radiologists, immunologists, endocrinologists, and hematologists.


All works published by OMICS International are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. JCMP strongly supports the Open Access initiative. Abstracts and full texts (HTML, PDF and XML format) of all articles published by JCMP are freely accessible to everyone immediately after publication. JCMP supports the Bethesda Statement on Open Access Publishing. 

» Journal of Cellular and Molecular Pharmacology focuses on a broad spectrum of topics related to this field, including but not limited to clinical and translational research, xenobiotic metabolism, Antibiotic and Anticancer drug action, toxicokinetics and toxicodynamics, pharmacogenomics and pharmacoproteomics, radiopharmacology, pharmacological agents on gene regulation, drug design and discovery, drug metabolism, drug-drug interactions, immunopharmacology, cell signaling, transduction pathway analysis, cancer metastasis, hematopoiesis, Angiogenesis, cell differentiation, apoptosis, biomarkers, and metabonomics.